Horizon Pharma | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.52B 1.73B 2024-12
ALKERMES USD 399.81M 108.66M 2025-03
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Bausch Health Companies USD 1.13B 47M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Merck USD 8.63B 4.61B 2025-03
Novartis USD 8.87B 4.74B 2024-12
Pacira USD 283.61M 6.84M 2025-03
Perrigo USD 409.9M 148.9M 2025-03
Pfizer USD 1.43B 387M 2025-03
Prestige Brands USD 97.88M 47.01M 2025-03
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Takeda JPY 385.11B 109.01B 2025-03
Xeris Pharmaceuticals USD 71.62M 12.39M 2024-12
Zoetis USD 1.72B 264M 2025-03



Horizon Pharma Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.